The Australian Academy of Science has developed a suite of measles educational and promotional materials for vaccination providers and consumers, to raise awareness about measles, with a particular focus on those most at risk of the disease such as travellers or those born during or from 1966.
GPs are reminded that measles-mumps-rubella (MMR) vaccine is free for all people born during or after 1966, who haven’t had measles or two doses of measles vaccine.
Australian Immunisation Handbook
The Australian Immunisation Handbook was recently updated. A summary of the updates is available. Changes include updates to a number of disease chapters, and various administrative updates to improve the usability of the Handbook, including updates to hyperlinks throughout the Handbook.
New presentation of Priorix and Priorix Tetra
GSK Australia has advised NSW Health that, over the next six months, the syringe presentations of Priorix and Priorix Tetra vaccines available in Australia will transition to Luer Lock Plastic Rigid Tip Caps, (the same fitting as Fluarix Tetra influenza vaccine).
Priorix Tetra is currently out of stock (ProQuad vaccine is being supplied as the measles-mumps-rubella-varicella (MMRV) vaccine for use in 18 month old children). NSW Health expects supply of Priorix Tetra vaccine to resume by January 2020.
Cold chain learning module
Thank you for your patience with the glitch that prevented individuals from printing a certificate on completion of the cold chain learning module. Certificates are now able to be printed on completion of the module.
Commonwealth’s HPV campaign launch
The Australian Government’s Department of Health has launched a human papillomavirus (HPV) vaccination communication campaign (including translations), aimed at increasing awareness and understanding of the benefits, importance, safety and efficacy of the HPV vaccine, and increasing uptake of the vaccine delivered in schools through the National Immunisation Program. The primary audience for the campaign is parents of young adults, and young adults aged up to 19 years who are eligible for free catch-up doses. A campaign news item is also available.